M
EW icon

Mirova’s Edwards Lifesciences EW Stock Holding History

Mirova’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.31M Buy
91,821
+87,577
+2,064% +$7.34M 0.31% 95
2026
Q1 		$340K Buy
4,244
+1,406
+50% +$116K 0.01% 172
2025
Q4 		$242K Sell
2,838
-71
-2% -$5.83K 0.03% 89
2025
Q3 		$226K Hold
2,909
– – 0.03% 105
2025
Q2 		$228K Buy
2,909
+1,766
+155% +$132K 0.03% 110
2025
Q1 		$82.8K Hold
1,143
– – 0.01% 126
2024
Q4 		$84.6K Sell
1,143
-5,296
-82% -$371K 0.01% 122
2024
Q3 		$425K Hold
6,439
– – 0.07% 97
2024
Q2 		$595K Hold
6,439
– – 0.11% 86
2024
Q1 		$615K Buy
6,439
+5,248
+441% +$441K 0.11% 78
2023
Q4 		$90.8K Sell
1,191
-72
-6% -$5.01K 0.02% 105
2023
Q3 		$87.5K Sell
1,263
-2,348
-65% -$189K 0.02% 107
2023
Q2 		$341K Sell
3,611
-4,045
-53% -$352K 0.06% 104
2023
Q1 		$633K Buy
7,656
+4,792
+167% +$377K 0.09% 99
2022
Q4 		$214K Sell
2,864
-2,154
-43% -$166K 0.03% 156
2022
Q3 		$414K Sell
5,018
-14,608
-74% -$1.41M 0.07% 127
2022
Q2 		$1.87M Buy
19,626
+16,268
+484% +$1.68M 0.27% 65
2022
Q1 		$395K Sell
3,358
-69
-2% -$7.74K 0.05% 131
2021
Q4 		$443K Sell
3,427
-2,084
-38% -$243K 0.05% 123
2021
Q3 		$623K Buy
5,511
+486
+10% +$55.5K 0.08% 107
2021
Q2 		$520K Sell
5,025
-353
-7% -$33.3K 0.06% 108
2021
Q1 		$449K Buy
5,378
+868
+19% +$73.4K 0.05% 108
2020
Q4 		$411K Buy
4,510
+4,028
+836% +$334K 0.05% 95
2020
Q3 		$38K Buy
482
+368
+323% +$28.7K 0.01% 140
2020
Q2 		$8K Hold
114
– – ﹤0.01% 163
2020
Q1 		$7K Hold
114
– – ﹤0.01% 163
2019
Q4 		$9K Buy
+114
New +$8.9K ﹤0.01% 165

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Mirova's EW Position: Q2 2026 in Review

Mirova increased its Edwards Lifesciences (EW) stake by 2,064% in Q2 2026, buying an estimated $7.34M and bringing the position to 91,821 shares worth $8.31M. The position accounts for 0.31% of the portfolio, ranked #95.

Mirova first reported a position in EW in Q4 2019 and has held it in 27 quarters since. 1,325 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Mirova held 91,821 shares of Edwards Lifesciences worth $8.31M as of Q2 2026.
  • Mirova bought 87,577 Edwards Lifesciences shares in Q2 2026, an estimated $7.34M.
  • Edwards Lifesciences made up 0.31% of Mirova's portfolio in Q2 2026, its #95 holding.
  • Mirova first reported a position in Edwards Lifesciences in Q4 2019 and has held it in 27 quarters since.
  • 1,325 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Mirova's 13F filing for Q2 2026, filed 13 Aug 2026.